Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study aims to unlock breast Cancer's molecular secrets

NCT ID NCT01840293

First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study is collecting tumor tissue from up to 1,780 people with primary or recurrent/metastatic breast cancer. Researchers will analyze proteins and genes in the tumors to better understand how breast cancer progresses and why it sometimes comes back. The goal is to find new markers that could guide future treatments, but this is a research study only and does not test any new drug or therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Beaumont Hospital

    RECRUITING

    Dublin, Ireland

    Contact

    Contact

    Contact Phone: •••-•••-••••

  • Cork University Hospital

    RECRUITING

    Cork, Ireland

    Contact Phone: •••-•••-••••

    Contact

  • St James's Hospital

    COMPLETED

    Dublin, Ireland

  • St. Vincent's University Hospital

    RECRUITING

    Dublin, Ireland

    Contact Phone: •••-•••-••••

    Contact

  • University Hospital Limerick

    ACTIVE_NOT_RECRUITING

    Limerick, Ireland

  • University Hospital Waterford

    RECRUITING

    Waterford, Ireland

    Contact Phone: •••-•••-••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help identify new markers or pathways that predict breast cancer recurrence or treatment response.

What could go wrong

This is an observational study, not a treatment trial. It may not directly lead to new therapies or immediate patient benefits.

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.